Sight Sciences Analyst Price Targets - Benzinga

Sight Sciences Inc

SGHTNASDAQ

Trade with Public

Trade with Public

$8.99

-0.1-1.1%

마지막 업데이트: Oct 22, 4:00 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Sight Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Sight Sciences (SGHT).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

5Buy

2Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$9Upside to Avg. PT+2.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$14
Oct 5, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$8→$10
Aug 17, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$6→$8
Aug 6, 2026	UBS	Patrick Wood	PT Raise	Buy	$7→$8
Jul 28, 2026	UBS	Patrick Wood	Assumes	Buy	$11→$7
Jul 8, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$5→$6
May 28, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$4→$5
Mar 6, 2026	UBS	Danielle Antalffy	PT Cut	Buy	$12→$11
Mar 6, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$9→$7
Mar 2, 2026	Stifel	Thomas Stephan	PT Raise	Buy	$6→$8
Jan 5, 2026	Piper Sandler	Adam Maeder	Upgrade	Neutral→Overweight	$5→$9
Dec 23, 2025	UBS	Danielle Antalffy	PT Raise	Buy	$7→$12
Dec 11, 2025	Citigroup	Joanne Wuensch	PT Raise	Neutral	$6→$9
Dec 10, 2025	Lake Street	Frank Takkinen	PT Raise	Buy	$7→$12
Dec 2, 2025	Morgan Stanley	Cecilia Furlong	PT Raise	Equal-Weight	$6→$8
Nov 10, 2025	Morgan Stanley	Cecilia Furlong	PT Raise	Equal-Weight	$4→$6
Nov 7, 2025	Piper Sandler	Adam Maeder	PT Raise	Neutral	$4→$5
Oct 21, 2025	Lake Street	Frank Takkinen	PT Raise	Buy	$5→$7
Oct 7, 2025	Citigroup	Joanne Wuensch	PT Cut	Neutral	$5→$4
Aug 28, 2025	Needham	David Saxon	Maintained	Hold	—

Analyst Ratings News

Why Is Sight Sciences Stock Gaining Thursday?

Sight Sciences (SGHT) stock jumped after H.C. Wainwright initiated coverage with a Buy rating and a $14 price target — nearly 70% upside.

Vandana Singh

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On Sight Sciences with Buy Rating, Announces Price Target of $14

HC Wainwright & Co. analyst Yi Chen initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Buy rating and announces Price Target of $14.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Sight Sciences, Raises Price Target to $8

UBS analyst Patrick Wood maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $7 to $8.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $6

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $5.15 to $6.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $5.15

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $4.35 to $5.15.

Benzinga Newsdesk